Crestline Management, LP Eli Lilly & CO Transaction History
Crestline Management, LP
- $2.93 Billion
- Q4 2024
A detailed history of Crestline Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Crestline Management, LP holds 16,241 shares of LLY stock, worth $14.2 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
16,241
Previous 2,200
638.23%
Holding current value
$14.2 Million
Previous $1.95 Million
543.3%
% of portfolio
0.43%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
4,264Shares Held
756MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$84.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$64.9 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$57.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$44.8 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$30 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $830B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...